M. A. Şendur Et Al. , "Necrotizing fasciitis secondary to bevacizumab treatment for metastatic rectal adenocarcinoma," Indian Journal of Pharmacology , vol.46, no.1, pp.125-126, 2014
Şendur, M. A. Et Al. 2014. Necrotizing fasciitis secondary to bevacizumab treatment for metastatic rectal adenocarcinoma. Indian Journal of Pharmacology , vol.46, no.1 , 125-126.
Şendur, M. A., AKSOY, S., Özdemir, N. Y., & ZENGİN, N., (2014). Necrotizing fasciitis secondary to bevacizumab treatment for metastatic rectal adenocarcinoma. Indian Journal of Pharmacology , vol.46, no.1, 125-126.
Şendur, Mehmet Et Al. "Necrotizing fasciitis secondary to bevacizumab treatment for metastatic rectal adenocarcinoma," Indian Journal of Pharmacology , vol.46, no.1, 125-126, 2014
Şendur, Mehmet A. Et Al. "Necrotizing fasciitis secondary to bevacizumab treatment for metastatic rectal adenocarcinoma." Indian Journal of Pharmacology , vol.46, no.1, pp.125-126, 2014
Şendur, M. A. Et Al. (2014) . "Necrotizing fasciitis secondary to bevacizumab treatment for metastatic rectal adenocarcinoma." Indian Journal of Pharmacology , vol.46, no.1, pp.125-126.
@article{article, author={Mehmet A.N. Şendur Et Al. }, title={Necrotizing fasciitis secondary to bevacizumab treatment for metastatic rectal adenocarcinoma}, journal={Indian Journal of Pharmacology}, year=2014, pages={125-126} }